Zurich to allow medicinal cannabis sales
Updated: Sep 21, 2021
It was announced recently that Switzerland’s largest city, Zurich, will next year allow people to buy cannabis products from pharmacies and social clubs under controlled conditions.
This article outlines the three-and-a-half year pilot scheme, known as the ‘Züri Can - Cannabis with Responsibility’ study. It will start in the (northern hemisphere) autumn of 2022, making different products available, each with a different THC/CBD content.
Local manufacturers will need to have a production permit from the Federal Office of Public Health, ensuring quality standards.
To understand the distinction between recreational use and medicinal use, as well as the importance of certification of products for medicinal cannabis throughout the supply chain, click here.
Looking for a professional partner to provide you with procurement, due diligence or compliance service for medical cannabis products, get in touch: greg@farmers2pharma.com.
